Our objective was to determine the discriminatory performance of a molecular RNA panel comprising FZD5 and GTF2I for the early identification of ischemic heart disease in individuals with type 2 diabetes mellitus. The gene discussed is FZD5; the disease is type 2 diabetes mellitus.